Review of Kidney Biopsies of Dent Disease Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02022189|
Recruitment Status : Completed
First Posted : December 27, 2013
Last Update Posted : September 22, 2015
|Condition or disease||Intervention/treatment|
|Dent Disease||Procedure: Renal Biopsy|
If the patient agrees to be in the study, the patient will be asked to participate in the following:
- Sign a consent form indicating the patient's willingness to participate.
- Provide a signed medical release form allowing the investigator to request your official kidney biopsy reports, and also allowing the investigator to request the original slides for review. At the end of the study, all slides will be returned to the referring facility.
- The investigator will also review your medical record
|Study Type :||Observational|
|Estimated Enrollment :||20 participants|
|Official Title:||Systematic Review of Clinical Biopsies of Dent Disease Patients|
|Study Start Date :||October 2013|
|Actual Primary Completion Date :||September 2015|
|Actual Study Completion Date :||September 2015|
Dent Disease patients
Patients with diagnosed Dent Disease
Procedure: Renal Biopsy
Other Name: All patients in the Dent Disease Registry with a previous renal biopsy.
- Biopsy changes [ Time Frame: 2 years ]The primary outcome will be to determine the number of glomeruli, percent globally sclerotic glomeruli, percent focally sclerotic glomeruli, and the severity of interstitial fibrosis (none, mild, moderate, severe) and interstitial crystals (none, mild, moderate, severe)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02022189
|United States, Minnesota|
|Rochester, Minnesota, United States, 55905|
|Principal Investigator:||John C Lieske, M.D.||Mayo Clinic|